Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Alport Syndrome

Alport syndrome is clinically characterized by a hereditary nephritis sensorineural deafness and a plethora of ocular abnormalities. The ultrastructural link between these different manifestations is a basement membrane disorder affecting highly differentiated basement membranes that are present in the glomerulum, organ of Corti and at some ocular localizations.

Epidemiology

About 1% of the whole population of dialysis patients suffer from Alport syndrome. It is the most common cause of dialysis among children, however. X-linked Alport syndrome caused by COL4A5 mutations is the most common form. It accounts for 80% of cases. Hence, most of the patients are male. The frequency of heterozygous carriers is 1 in 1000.

Test Strategy

If tumors and inflammatory processes are excluded, a positive family history and a hematuria seems to be sufficient reasons for genetic testing particularly in female. Renal biopsy is recommended in these cases only where family history and clinical symptoms are not typical or mutation screening did not succeed in detecting the relevant mutation.

Pathogenesis

On the molecular level we find disturbances of collagen type IV caused by mutations in one of the genes COL4A5, COL4A4 or COL4A3.

Registry

EARLY PRO-TECT Alport

Symptoms

Hematuria
Hematuria is an early sign of Alport syndrome occuring in early childhood. In heterozygous carriers it remains the only abnormality.
Proteinuria
Proteinuria is seldom the leading symptom in Alport syndrome. It usually occurs after hematuria and almost never reaches nephrotic range.
Deafness
Progressive sensorineural deafness occurs in about 75% of cases.

Systematic

Glomerular basement membrane disorders
Alport Syndrome
COL4A3
COL4A4
COL4A5
HANAC syndrome
Leiomyomatosis with Alport syndrome, Smooth muscle tumors and Alport syndrome
MYH9 related disorders
Nail-patella syndrome
Nephropathy with pretibial epidermolysis bullosa and deafness
PXDN
Thin basement membrane nephropathy

References:

1.

Nagel M et al. (2005) Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome.

external link
2.

Gross O et al. (2003) Novel COL4A4 splice defect and in-frame deletion in a large consanguine family as a genetic link between benign familial haematuria and autosomal Alport syndrome.

external link
3.

Jais JP et al. (2003) X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study.

external link
4.

Browne G et al. (2004) Retransplantation in Alport post-transplant anti-GBM disease.

external link
5.

Imai E et al. (2004) Perspectives for gene therapy in renal diseases.

external link
6.

Ninichuk V et al. (2005) Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.

external link
7.

Ninichuk V et al. (2006) Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient mice.

external link
8.

Beirowski B et al. (2006) Chronic renal failure and shortened lifespan in COL4A3+/- mice: an animal model for thin basement membrane nephropathy.

external link
9.

Rao VH et al. (2006) Role for macrophage metalloelastase in glomerular basement membrane damage associated with alport syndrome.

external link
10.

Floege J et al. (2006) Bone marrow transplantation rescues Alport mice.

external link
11.

Prodromidi EI et al. (2006) Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.

external link
12.

Alves FR et al. () Revision about hearing loss in the Alport's syndrome, analyzing the clinical, genetic and bio-molecular aspects.

external link
13.

None (2006) Renal transplantation in patients with Alport syndrome.

external link
14.

OMIM.ORG article

Omim 301050 external link
15.

Orphanet article

Orphanet ID 63 external link
16.

Wikipedia article

Wikipedia EN (Alport_syndrome) external link
Update: Aug. 14, 2020
Copyright © 2005-2024 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues | Website Credits